P
Protagonist Therapeutics D
D
PTGX
99.830
USD
-2.80
(-2.73%)
مغلق
حجم التداول
18,650
الربح لكل سهم
4
العائد الربحي
-
P/E
-49
حجم السوق
6,370,024,118
المقالات
العنوان: Protagonist Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
